These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16728460)

  • 41. [Diagnosis and therapy of vasculitic neuropathy. Consensus statement of the German Centers for Neuromuscular Disease].
    Heuss D; Schlotter-Weigel B; Sommer C;
    Fortschr Neurol Psychiatr; 2003 Apr; 71(4):172-86. PubMed ID: 12677551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vasculitis in children and adolescents.
    Dillon MJ; Ansell BM
    Rheum Dis Clin North Am; 1995 Nov; 21(4):1115-36. PubMed ID: 8592740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent developments in the classification and assessment of vasculitis.
    Watts RA; Scott DG
    Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):429-43. PubMed ID: 19508949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Scientifically based patient education exemplified by patients with primary systemic vasculitis. The vasculitis patient education program--development, contents and initial results of evaluation].
    Herlyn K; Höder J; Gross WL; Reinhold-Keller E
    Z Rheumatol; 2002 Feb; 61(1):13-20. PubMed ID: 11974487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit.
    Cruz BA; Ramanoelina J; Mahr A; Cohen P; Mouthon L; Cohen Y; Hoang P; Guillevin L
    Rheumatology (Oxford); 2003 Oct; 42(10):1183-8. PubMed ID: 12777637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Systemic ANCA-associated vasculitis--diagnosis and therapy].
    Eisenberger U; Hess C
    Ther Umsch; 2008 May; 65(5):295-301. PubMed ID: 18622935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.
    Jayne DR; Rasmussen N
    Mayo Clin Proc; 1997 Aug; 72(8):737-47. PubMed ID: 9276602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.
    Mukhtyar C; Luqmani R
    Clin Exp Rheumatol; 2007; 25(6 Suppl 47):120-9. PubMed ID: 18021517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Glomerulonephritis and vasculitis as causes of arterial hypertension].
    Eicken S; Gugger M; Marti HP
    Ther Umsch; 2012 May; 69(5):283-94. PubMed ID: 22547360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Role of 18F Fluorodeoxyglucose Positron Emission Tomography Scanning in the Diagnosis and Management of Systemic Vasculitis.
    Danve A; O'Dell J
    Int J Rheum Dis; 2015 Sep; 18(7):714-24. PubMed ID: 26177990
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Disability in systemic vasculitis].
    Lavrova DI
    Revmatologiia (Mosk); 1985; (3):32-3. PubMed ID: 3903927
    [No Abstract]   [Full Text] [Related]  

  • 52. [Diagnosis and course assessment of collagenoses and vasculitides].
    Fontana A; Widmer U; Speich R; Michel B
    Schweiz Med Wochenschr; 1994 Jun; 124(25):1096-102. PubMed ID: 8029682
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biopsy diagnosis of systemic vasculitis.
    Lie JT
    Baillieres Clin Rheumatol; 1997 May; 11(2):219-36. PubMed ID: 9220076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Update on vasculitis.
    Khasnis A; Langford CA
    J Allergy Clin Immunol; 2009 Jun; 123(6):1226-36. PubMed ID: 19501230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunological diagnosis of vasculitis.
    Abdul-Aziz K; Faizal AA
    Saudi Med J; 2006 Aug; 27(8):1105-15. PubMed ID: 16883435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials.
    Robson J; Doll H; Suppiah R; Flossmann O; Harper L; Höglund P; Jayne D; Mahr A; Westman K; Luqmani R
    Rheumatology (Oxford); 2015 Mar; 54(3):471-81. PubMed ID: 25205825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapy insight: The recognition and treatment of retinal manifestations of systemic vasculitis.
    Aristodemou P; Stanford M
    Nat Clin Pract Rheumatol; 2006 Aug; 2(8):443-51. PubMed ID: 16932736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systemic vasculitis and patient-reported outcomes: how the assessment of patient preferences and perspectives could improve outcomes.
    Robson JC; Jayne D; Merkel PA; Dawson J
    Patient Relat Outcome Meas; 2019; 10():37-42. PubMed ID: 30804691
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vasculitis in systemic lupus erythematosis.
    Calamia KT; Balabanova M
    Clin Dermatol; 2004; 22(2):148-56. PubMed ID: 15234016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [New insights in the treatment of ANCA-associated systemic vasculitis].
    Sinico RA; Sabadini E
    G Ital Nefrol; 2006; 23(2):138-48. PubMed ID: 16710819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.